Clinical Trials in Chicago

Showing 2501-2520 of 20,493 trials

Not Yet RecruitingEARLY Phase 12.2 miles

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

NCT07410312

This study will determine if primary graft dysfunction (which causes low blood oxygen levels and fluid or inflammation in the lungs) after lung transplant can be prevented through the use of the study drug (IL-1 receptor antagonist, Anakinra). In this study, lung transplant participants who are randomized to the treatment group will have the study drug injected into the solution that their donor lungs are kept in prior to transplant.

Lung Transplant Recipient

Northwestern University20 participantsStarted Feb 2026

Chicago, Illinois, United States

Active Not RecruitingNA2.2 miles

Eliminating Monitor Overuse Trial (EMO Trial)

NCT05132322

The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with bronchiolitis who are not receiving supplemental oxygen.

Bronchiolitis Acute Viral

Children's Hospital of Philadelphia9,265 participantsStarted Dec 2021

Birmingham, Alabama, United States • Davis, California, United States • Encinitas, California, United States +48 more locations

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

Eliminating Monitor Overuse Trial (EMO Trial)

Find Trials by Condition in Chicago

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

5-SENSE Score Validation Study

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

Safety and Immunogenicity of NVX-CoV2705

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Belimumab With Rituximab for Primary Membranous Nephropathy

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

REFLECT Scoliosis System Post Approval Study

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH